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ACTH is a major hormone of the stress axis or hypothalamic-pituitary-adrenal (HPA) axis.  It is derived from pro-
opiomelanocortin (POMC) the precursor to the melanocortin family of peptides. POMC produces the biologically active 
melanocortin peptides via a series of enzymatic steps in a tissue-specific manner, yielding the melanocyte-stimulating hormones 
(MSHs), corticotrophin (ACTH) and β-endorphin. The melanocortin system plays an imperative role in energy expenditure, 
insulin release and insulin sensitivity.  Bone marrow derived mesenchymal stem cells circulate in the blood stream and as 
progenitor cells have the potential to differentiate into many cell types such as osteoblasts, chondrocytes and adipocytes. Here we 
examine the effects of ACTH on the mouse D1 bone marrow-derived MSC.  ACTH significantly increased lipid accumulation 
during the adipogenic differentiation of D1 cells in a concentration- dependent manner. ACTH also shifts the temporal pattern of 
D1 adipogenic differentiation to the left i.e. differentiation occurs earlier with ACTH treatment. No significant differences in 
protein expression of peroxisome proliferator-activated receptor gamma (PPAR-γ2), a regulating transcription factor of 
adipogenesis were found.  Therefore the effects of ACTH are suggested to be mediated by an alternative pathway. Overall the 
results indicate a connection between increased adipose deposition and the elevated circulating ACTH associated with stress.   
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Introduction 
  
 The melanocortin system has been extensively studied 
and has become one of the most defined neuronal pathways 
involved in the stress response and maintaining homeostasis 
[1]. During stress, pro-opiomelanocortin (POMC) production 
in the pituitary is increased along with adrenocorticotrophin 
(ACTH) which is then released into the blood stream.  ACTH 
then elicits release of glucocorticoid from the adrenal cortex.  
Glucocorticoid in turn facilitates the body’s response to stress 
by mobilizing glucose stores.  It also feeds back on the 
pituitary and hypothalamus to turn off the production of 
ACTH.  This endocrine negative feedback system is known as 
the hypothalamic-pituitary-adrenal (HPA) axis [2].   
Overactivation of this axis is linked to obesity with the fat 
distributed primarily in the abdomen [3].  
POMC is the precursor to ACTH as well as many other 
melanocortin peptides. The biologically active melanocortin 
peptides are produced from POMC through a series of 
enzymatic steps in a tissue-specific manner, producing the 
melanocyte-stimulating hormones (MSHs), ACTH and β-
endorphin [4]. The effects of melanocortin peptides are 
regulated by the activation of specific melanocortin receptors 
which differ from each other in terms of their tissue 
distribution and affinity for the melanocortin agonists and 
antagonists.  The melanocortin receptors (MC-R) are a family 
of G-protein coupled receptors (GPCR).  There are five 
melanocortin receptors, termed MC1-5-R and all can be 
activated by ACTH [5].  GPCRs make up the largest and most 
diverse family of membrane receptors. GPCRs transduce 
varying stimuli from external signals and ligands such as 
neurotransmitters, peptides, lipids, nucleotides, ions, 
pheromones, tastes and odors.  GPCRs have the ability to 
signal through G-proteins to regulate adenylate cyclase and 
modify cAMP production [6]. 
The melanocortin peptides and their receptors have many 
physiologic roles both inside and outside of the central 
nervous system.  In the central nervous system they signal 
through MC-R expressed in the hypothalamus and are active 
in appetite regulation and energy expenditure [1].  Outside the 
central nervous system they play roles in skin pigmentation 
[7], in exocrine gland secretion [8] and the ostoechondrogenic 
differentiation of progenitor cells [9,10].    
  Our focus is on the role of the melanocortin peptide, 
ACTH, in the adipogenic differentiation of bone marrow-
derived mesenchymal stem cells (BMSC).  BMSC are 
pluripotent progenitor cells that can differentiate into many 
different cell types such as chondrocytes, osteocytes and 
adipocytes. BMSC are precursors of connective tissue cells 
and will migrate to damaged and inflamed tissues to aid in 
repair [11].  The MC2-R, MC3-R and MC5-R are expressed 
by circulating BMSC [9] and all of these receptors can be 
activated by the ACTH ligand and result in elevations of 
cAMP [5].  Moderate increases in intracellular cAMP are 
linked to the adipogenic differentiation of BMSC.  The 
cAMP-response element binding protein (CREB), activated 
by cAMP, has key functions in adipocyte differentiation.  It 
binds to known cAMP response elements (CRE) located on 
multiple adipocyte gene promoters including the PPARγ2 
adipocyte specific transcription factor leading to adipogenic 
differentiation [12]. The fact that ACTH by binding to MC-R 
located on the BMSC can result in elevations in cAMP led us 
to hypothesize that ACTH will enhance adipogenesis of bone-
marrow derived mesenchymal stem cells.  
Our first aim was to optimize the adipogenic induction 
protocol to a level below saturation to allow for the detection 
of any effect of ACTH. This was done by carrying out 
adipogenic induction of D1 bone-marrow derived MSC with 
one-quarter, one-half and at full strength of the standard 
induction agents. We also wanted to determine the effect of 
ACTH on lipid accumulation and PPARγ2 protein expression 
during the adipogenic differentiation. Using the protocol 
optimized in aim 1, MSC were induced to form adipocytes in 
the presence or absence of ACTH at a range of 
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concentrations. Lipid accumulation and PPARγ2 protein 
expression were measured over a five day period.  
 
Materials and Methods 
 
Materials 
 Cell culture reagents were obtained from Invitrogen, 
unless otherwise specified. Porcine ACTH (1-39) was 
purchased from Sigma-Aldrich as well as all other chemicals. 
All primary and secondary antibodies were from Santa Cruz 
Biotechnology (Santa Cruz, CA).  
 
Cell Culture 
D1 ORL UVA (D1) cells, a bone marrow-derived 
mesenchymal stem cell line, were obtained from the 
American Type Culture Collection (ATCC #CRL-12424) and 
were maintained in culture with high glucose DMEM 
supplemented with 10% FBS, 100 U/mL penicillin sodium, 
100 U/mL streptomycin sulfate, and 0.25 µg/mL amphotericin 
B. Cells were used at passage 5. The cells were initiated at a 
density of 6.25 x 103 cells/cm2. 
 
Adipogenic Induction 
 At confluence, culture medium was changed to 
experimental media (αMEM supplemented with 10% FBS, 
100 U/mL penicillin sodium, 100 U/mL streptomycin sulfate, 
and 0.25 µg/mL amphotericin B and treated with a full 
strength adipogenic induction cocktail (1 μM dexamethasone, 
10 μg/mL insulin, 0.5 mM isobutyl methylxanthine (IBMX) 
and 15 mM glucose) to induce adipocyte differentiation. One 
half and one quarter induction cocktail concentrations were 
also used. Cells were exposed to induction medium for 2 days 
before being changed to experimental medium without 
induction cocktail.  Medium was changed every two days 
until experiment completion (Day 5 or 7.) Final induction 
strength of one quarter of full strength was used for 
adrenocorticotropic hormone (ACTH) experimentation.  
ACTH was added on the day of adipogenic induction (day 0) 
at concentrations of 10 nM, 100 nM and 1000 nM. 
 
Neutral Lipid Staining 
 Cell cultures were washed with PBS and fixed with 10% 
Formalin at room temperature for 30 minutes. Cells were then 
stained using Oil-red-O (0.5 g Oil-red-O in 100 mL 
isopropanol) for 15 minutes. Oil-red-O solution used 
contained 60% Oil-Red-O and 40% diH20 in mixture. After 
staining, cells were rinsed four times with distilled water and 
wells were cleaned to remove excess stain. Oil-red-O stain 
was re-solubilized with isopropanol. Samples from each 
culture well were taken and measured by spectrophotometry 
at a 490 nm wavelength.  
 
 
 
 
 
 
Image Analysis  
   Initial adipogenic induction was analyzed by ImageJ 
retrieved online from The National Institutes of Health 
(http://rsb.info.nih.gov/ij/). Images were captured using an 
inverted phase-contrast microscope coupled to a camera.  The 
program allowed for the quantification of lipid accumulation 
in stained cell cultures. The threshold in ImageJ was set to 
detect the red color of the neutral lipid and measured the area 
of red color in the images. Multiple random images were 
captured of each well and used in the comparative analysis.  
 
Western Blot Analysis 
 Proteins were extracted from the cell layers using radio-
immunoprecipitation assay (RIPA) buffer.  Protein 
concentrations were determined by the bicinchoninic acid 
(BCA) assay. Protein separation was performed with SDS-
PAGE and transferred to a polyvinylidene difluoride 
membrane. Non-specific blocking of the membrane was done 
using blocking buffer (tris-buffered saline with Tween and 
5% w/v non-fat dry milk) for an hour then incubated with 
PPARγ2 primary antibody (1:1000 dilution) overnight. Upon 
incubation completion, membranes were washed with TBST 
solution for a total of three times.  To detect the primary 
antibody, a HRP-labeled secondary anti-rabbit IgG antibody 
was added to blocking buffer (1:2000 dilution) and incubated 
with the membrane for an hour. PPARγ detection was 
performed by visualizing bands using enhanced 
chemiluminescence (ECL).   
 
Statistical Analysis 
Data were analyzed using two-way ANOVA with time 
and treatment as factors. 
 
Results 
 
Optimization of the adipogenic induction protocol 
 The first objective was to determine an optimal level of 
adipogenic induction; one that would induce adipogenesis of 
D1 cells at a sub-optimal level to allow for detection of 
ACTH effects.  Confluent cultures were exposed to an 
adipogenic induction cocktail at full, one-half and one-quarter 
strengths. A cocktail consisting of 0.5mM isobutyl 
methylxanthine, 1 µM dexamethasone, and 10 µg/mL insulin 
was considered full strength.  The full strength and one-half 
strength induction resulted in saturation by day 4 or day 7 of 
culture respectively. The induction cocktail at one-quarter 
strength did not reach saturation at 7 days making it the most 
effective concentration for our future experiments (Fig. 1).   
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ACTH increases adipogenesis of D1 MSC in a concentration dependent manner and shifts the peak of differentiation to 
an earlier time point 
 
When D1 cells were induced to form adipocytes in the 
presence of ACTH there was a significant increase in 
adipogenesis at early time points; day 1 and day 2. This 
increase was dependent on concentration of ACTH; 
adipogenesis increased with increasing concentrations of 
ACTH (Fig. 2).  ACTH treated cultures also reached peak 
lipid accumulation at day 3 whereas untreated cultures 
reached peak lipid accumulation at day 5 (Fig. 3).  
 
 
Figure 2: ACTH increases lipid accumulation early during 
adipogenic induction of D1 MSC.  Absorbance of oil-red-o 
stain extracted from cell layers of ACTH treated cultures was 
measured and normalized to untreated cultures of 
corresponding time points. Data are presented as mean ± 
SEM, n = 4.  Two-way ANOVA using ACTH treatment and 
time as factors indicates a significant effect of treatment, P = 
0.0116 and time P = 0.0001 on lipid accumulation. Data are 
representative of 3 experiments with similar results. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3: Induction with ACTH supplementation shifts peak 
lipid accumulation in D1 MSC. Absorbance of oil-red-o stain 
extracted from cell layers was plotted in a line graph to 
demonstrate the shift in peak lipid accumulation.  Data 
presented as mean ± SEM, n = 4.  
ACTH does not increase PPARγ protein expression 
 
PPARγ2 is a transcription factor that is capable of 
activating the expression of many genes promoting 
adipogenesis [13].  We tested the hypothesis that ACTH 
exerts its effects through increasing the expression of 
PPARγ2. Using western blot we compared the expression of 
PPARγ2 in D1 cultures induced to form adipocytes in the  
 
 
 
 
presence or absence of ACTH at 100 nM. PPARγ2 expression 
increased with differentiation in both treated and untreated 
cultures confirming adipogenic differentiation.  When 
comparing expression between ACTH treated and untreated 
cultures we found no significant difference in PPARγ2 
expression levels. This shows that ACTH had no effect on the 
expression of PPARγ (Fig. 4 A&B).   
 
 
 
Figure 1: The effects of induction factors on lipid accumulation at a range of concentrations. Concentrations of 1µM 
DEX, 10µg/mL insulin, 0.5mM IBMX and 15mM glucose were used for full induction (A) one-half (B) and one-
quarter (C) were adjusted accordingly. Images shown in A-C were from day 7.  Images were captured using an inverted 
phase-contrast microcope coupled to a camera.  Images were analyzed using ImageJ.  The threshold was set to detect 
the red color of the neutral lipid after staining.  The threshold area was determined for 3 images per well x 4 wells 
under each condition and data are presented as the mean ± SEM, n = 12 in (D).  
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Figure 4: Protein expression of the PPARγ2 adipogenic transcription factor is not increased by ACTH treatment. (A) A 
representative western blot demonstrating PPARγ expression in untreated and ACTH treated (100 nM) cultures. (B) A bar graph 
of the relative band intensities in A.  Data are presented as the mean ± SEM of 3 different experiments.  Two-way ANOVA 
analysis with ACTH treatment and time as factors show no significant effect of treatment, P = 0.44 but a significant effect of 
time, P = 0.0119 on PPARγ expression. 
 
Discussion 
 
 Many previous works have used the 3T3-L1 pre-
adipogenic cell line to examine the effects of melanocortin 
peptides in adipogenesis [14].  The melanocortin peptides 
induce interleukin 6 (IL-6) production from this cell line as 
well as induce lypolysis or the breakdown of these fat cells 
[15, 16].  IL-6 is a pleiotropic cytokine secreted by many cell 
types and plays an active role in tissue inflammation [16].  
The current study focuses on the response of bone-marrow 
derived mesenchymal stem cells to ACTH during adipogenic 
differentiation.  The D1 ORL UVA cell line, capable of 
osteogenic and adipogenic differentiation, was first described 
by Diduch et.al. [17].  This cell line represents an earlier  
 
progenitor than the 3T3-L1 cell line which is already 
committed to the adipocyte lineage.   The difference in 
lineage commitment between these two cell lines may explain 
why others did not find an enhancement of adipogenesis by 
ACTH using 3T3-L1 cultures [14] and the current studies find 
ACTH enhances adipogenesis in D1 cells.    
3T3-L1 cultures express the MC2-R and MC5-R after 
differentiation and signaling through these receptors enhances 
lipolysis in a cAMP dependent manner [14].  Conversely, 
bone marrow mesenchymal stem cells express the MC2-R and 
MC5-R prior to differentiation and signaling through 
receptors can enhance osteochondrogenic differentiation [9].  
Here we also demonstrate that under adipogenic conditions, 
ACTH can enhance lipid accumulation in the D1 cell line and 
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this is presumably through MC-R signaling and the 
enhancement of cAMP accumulation.  More studies are 
needed to make these determinations.  
It was found that PPAR-γ2 was not involved in 
adipogenesis when induced by DEX in D1 cells [13]. We 
found similar results, showing that ACTH-induced elevated 
lipid accumulation in D1 cells was not mediated through 
increased expression of PPAR-γ2. This suggests that the 
effects of ACTH are mediated by an alternative 
transcriptional pathway.   
Glucocorticoid is another primary hormone of the HPA 
stress-axis has been implicated as the primary hormone 
involved in stress-related obesity [3].  The synthetic 
glucocorticoid, dexamethasone, is a component of the 
standard induction cocktail.  Therefore our data suggest that 
increased stress with the subsequent increase in circulating 
ACTH and glucocorticoid may prime circulating bone-
marrow derived mesenchymal stem cells for adipogenic 
differentiation and contribute to adipose.  This may in part 
account for stress-related redistribution of fat stores.  
 
Future Research  
 
 The mechanisms of ACTH and dexamethasone effects 
on adipogenic differentiation of BMSCs remain unclear and 
require further investigation.  Therefore studies using specific 
MC-R receptor agonist and antagonists to determine which 
melanocortin receptor expressed on the BMSC surface is 
responding to ACTH treatment are warranted.  Additional 
investigations aimed at finding other transcription factors, 
activated by cAMP, that may be involved in ACTH-induced 
adipogenic differentiation such as the CAAT-enhancer 
binding proteins (C/EBP) would also provide further insight 
into the mechanisms behind ACTH-enhanced adipogenesis in 
this cell line. 
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